News | December 07, 2022
Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operations
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
New deal strengthens Congenica’s presence in India
Subscribe To Our Newsletter & Stay Updated
